Biological warfare: agents, history, methods, and controls

Characteristics and categories

Biological agents fall into broad categories: bacteria (for example, Bacillus anthracis), viruses (for example, variola virus which causes smallpox), fungi, and biological toxins (such as botulinum toxin). They differ in contagiousness, incubation period, severity, and environmental persistence. Delivery methods include aerosol dissemination, contamination of food or water, use of infected vectors, or placement on clothing and other materials (for instance contaminated fabrics). Dual-use research — work that advances science but could be repurposed for harm — complicates control and oversight.

History and notable episodes

Deliberate use of biological agents dates back centuries. Historical accounts describe the tossing of infected corpses during sieges; some historians point to episodes in the Mongol campaigns (Mongol sieges) as early examples. Pre-modern tactics also included deliberate poisoning of food and water. Allegations and documented campaigns appear throughout history, with significant twentieth-century examples. During the Second Sino-Japanese War a Japanese program operated experimental units that deployed vectors and contaminated supplies against populations in China, an episode that influenced later international prohibition efforts.

Delivery, effects and examples

Methods of use have ranged from covert contamination of supplies to overt aerosol attacks. Historic reports include spreading infected fleas or contaminating food dropped from aircraft; modern scenarios model aerosol release in crowded settings to maximize spread. Effects depend on agent properties: some cause localized outbreaks, others can spark epidemics. Public health impacts include immediate casualties, long-term disability, fear, disruption of services, and economic damage.

Legal controls and responses

International law has progressively restricted biological warfare. The 1925 Geneva Protocol banned the battlefield use of chemical and biological agents, and the 1972 Biological Weapons Convention (BWC) prohibits development, production and stockpiling of biological weapons. National biodefence programs focus on surveillance, rapid diagnosis, vaccines, and response planning. Transparency, verification, and scientific norms are central but enforcement remains challenging because many biological capabilities are dual-use.

Prevention, detection and modern challenges

• Prevention: biosafety practices, secure laboratory procedures, export controls and ethical oversight of research.
• Detection: environmental monitoring, clinical surveillance and laboratory diagnostics to identify unusual disease patterns.
• Response: vaccination, medical countermeasures, quarantine, and coordinated public-health interventions.

Understanding biological threats requires combining historical lessons with current science and robust public-health systems. International cooperation, strong public-health infrastructure and clear legal norms aim to reduce the risks posed by deliberate use of biological agents while enabling legitimate research to improve health.

Further reading: definitions and background resources are available via related entries on pathogens, weapons and the concept of biological weapons, and case studies of the Second Sino-Japanese War and responses to outbreaks such as smallpox.